Tag: oral

Preclinical insights into dosing for first-in-human in vivo liver-directed gene therapy for MMA delivered in an oral presentation at the ASGCT Annual Meeting

PRESS RELEASEPreclinical insights into dosing for first-in-human in vivo liver-directed gene therapy…

GlobeNews Wire GlobeNews Wire
undefined

Applied Therapeutics Announces Acceptance of Late-Breaking Abstract for Oral Presentation at the Peripheral Nerve Society 2025 Annual Meeting

Late-breaking oral presentation to include full 12-month clinical data from INSPIRE registrational…

GlobeNews Wire GlobeNews Wire
undefined

EnteroBiotix Announces Oral Presentation of Phase 2a IBS-C Results at Digestive Disease Week 2025

April 28, 2025 03:00 ET  | Source: EnteroBiotix EnteroBiotix Announces Oral Presentation…

GlobeNews Wire GlobeNews Wire
undefined

Vantage Biosciences Doses First Patient in Phase 2 Clinical Study of Oral VX-01 for Non-Proliferative Diabetic Retinopathy

LONDON, April 11, 2025 (GLOBE NEWSWIRE) -- Vantage Biosciences, a clinical stage…

GlobeNews Wire GlobeNews Wire
undefined

Anavex Life Sciences Announces Positive up to 4-Years Oral Blarcamesine Results from Phase IIb/III Open-Label Extension Trial in Early Alzheimers Disease

ATTENTION-AD trial data through 192 weeks presented at AD/PDTM 2025 Conference Prespecified…

GlobeNews Wire GlobeNews Wire
undefined

Novo Nordisk A/S: Rybelsus (oral semaglutide 14 mg) demonstrates superior reduction in cardiovascular events in the SOUL trial at ACC 2025

Rybelsus® reduced major adverse cardiovascular events by 14% vs placebo in adults…

GlobeNews Wire GlobeNews Wire
undefined

Novartis receives third FDA approval for oral Fabhalta (iptacopan) the first and only treatment approved in C3 glomerulopathy (C3G)

Novartis receives third FDA approval for oral Fabhalta® (iptacopan) – the first…

GlobeNews Wire GlobeNews Wire
undefined